Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Invitris logo — Breaking Biology Free

Invitris

Breaking Biology Free

Founded 2022 United States Dover, United States 22 employees Pre Seed Total: $500.00K Biopharma, Biotechnology +1

General Information

Company Name Invitris
Founded Year 2022
Location United States Dover, United States +2
Employees 22
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Pre Seed
Social

Get notified when Invitris moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Invitris is demonstrating a proactive long-term strategic approach to market engagement by planning to participate in Swiss Biotech Day 2026 through its Business Development Lead. This early involvement in a prominent industry event, well in advance of its current Pre-Seed stage, signals a focus on networking and fostering future partnerships. Such forward-looking activity is crucial for a biotech platform focused on protein-based drug development, hinting at a strategic push for collaborations or a larger funding round.

Signal Types
Event Participation Business Development
Strategic Labels
Market Engagement Partnership Building Long-term Strategy
Next Move: Fundraising
·
Impact: 6/10
·
Ideal For: Early Stage Biotech VCs — Pre Seed/Seed

About Invitris

Invitris is a pioneering startup in the field of synthetic biology, carving a niche in the development of innovative protein-based drugs. The company's proprietary biotech platform, Phactory, stands out for its 10,000x higher efficiency in designing synthetic proteins and a remarkable 100x reduction in material costs. Leveraging this innovative technology, Invitris is at the forefront of developing the next generation of protein-based drugs, particularly focusing on novel classes of antibiotics.

Founded in 2022 and headquartered in Germany, Invitris recently secured a significant $500.00K Pre Seed Round investment on 05 April 2023, with backing from renowned tech accelerator Y Combinator. With this injection of capital and the trailblazing potential of its technology, Invitris is poised to lead the way in revolutionizing the biopharma, biotechnology, and pharmaceutical industries.

Taxonomy: Synthetic Biology, Biotech Platform, Protein-based Drugs, Phactory, Innovation, Drug Development, Antibiotics, Protein Design, Patent-pending, Material Cost Reduction, Biopharmaceuticals, Bioengineering, Biomedical Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $500.00K 1
Y Combinator
05 Apr 2023

Invitris Alternatives & Competitors

Invitris vs
Happy Plant Protein
Happy Plant Protein Finland

We keep it beautifully simple. One step transforms ordinary flour into high-value Happy plant protei...

Seed
6 employees
Invitris vs
AI Proteins
AI Proteins

AI Proteins designs next-generation biologics using AI for precision, scale, and safety.

Invitris vs
Sunbloom Proteins GmbH
Sunbloom Proteins GmbH Germany

We simplified protein. Nature perfected the taste. Experience our sunflower proteins difference!

Series A
14 employees
Food and Beverage

FAQ About Invitris

Breaking Biology Free
Invitris was founded in 2022.
Invitris is headquartered in Dover, United States.
Invitris operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Invitris has approximately 22 employees.
Invitris has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Pre Seed.
Top alternatives and competitors to Invitris include Happy Plant Protein, AI Proteins, Sunbloom Proteins GmbH, Loopworm, Real Deal Milk. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Invitris and Happy Plant Protein are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Invitris and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy